You are here

Home

Biblio

Author Title Type [ Year(Asc)]
Filters: Keyword is Aged, 80 and over  [Clear All Filters]
2021
Deters KD, Napolioni V, Sperling RA, Greicius MD, Mayeux R, Hohman T, Mormino EC.  2021.  Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study.. Neurology. 96(11):e1491-e1500.
Rizvi B, Lao PJ, Chesebro AG, Dworkin JD, Amarante E, Beato JM, Gutierrez J, Zahodne LB, Schupf N, Manly JJ et al..  2021.  Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.. JAMA Netw Open. 4(10):e2125166.
Walker JM, Fudym Y, Farrell K, Iida MA, Bieniek KF, Seshadri S, White CL, Crary JF, Richardson TE.  2021.  Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease.. J Neuropathol Exp Neurol. 80(5):436-445.
Andrews SJ, Fulton-Howard B, O'Reilly P, Marcora E, Goate AM.  2021.  Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome.. Ann Neurol. 89(1):54-65.
de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I et al..  2021.  Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.. Nat Commun. 12(1):3417.
Avila JF, Rentería MArce, Jones RN, Vonk JMJ, Turney I, Sol K, Seblova D, Arias F, Hill-Jarrett T, Levy S-A et al..  2021.  Education differentially contributes to cognitive reserve across racial/ethnic groups.. Alzheimers Dement. 17(1):70-80.
Griswold AJ, Celis K, Bussies PL, Rajabli F, Whitehead PL, Hamilton-Nelson KL, Beecham GW, Dykxhoorn DM, Nuytemans K, Wang L et al..  2021.  Increased APOE ε4 expression is associated with the difference in Alzheimer's disease risk from diverse ancestral backgrounds.. Alzheimers Dement. 17(7):1179-1188.
Ramos J, Chowdhury AR, Caywood LJ, Prough M, M Fuzzell D, Fuzzell S, Miskimen K, Whitehead PL, Adams LD, Laux R et al..  2021.  Lower Levels of Education Are Associated with Cognitive Impairment in the Old Order Amish.. J Alzheimers Dis. 79(1):451-458.
Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JPaul, Teich AF et al..  2021.  Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.. Alzheimers Dement. 17(8):1353-1364.
Sariya S, Felsky D, Reyes-Dumeyer D, Lali R, Lantigua RA, Vardarajan B, Jimenez-Velazquez IZ, Haines JL, Shellenberg GD, Pericak-Vance MA et al..  2021.  Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.. Ann Neurol. 90(3):366-376.
Ramos-Miguel A, Jones AA, Petyuk VA, Barakauskas VE, Barr AM, Leurgans SE, De Jager PL, Casaletto KB, Schneider JA, Bennett DA et al..  2021.  Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample.. Acta Neuropathol. 141(5):755-770.
Patel D, Zhang X, Farrell JJ, Lunetta KL, Farrer LA.  2021.  Set-Based Rare Variant Expression Quantitative Trait Loci in Blood and Brain from Alzheimer Disease Study Participants.. Genes (Basel). 12(3)
2020
Raghavan NS, Dumitrescu L, Mormino E, Mahoney ER, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD et al..  2020.  Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease.. JAMA Neurol. 77(10):1288-1298.
Belloy ME, Napolioni V, Han SS, Le Guen Y, Greicius MD.  2020.  Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.. JAMA Neurol. 77(7):849-862.
Blue EE, Cheng A, Chen S, Yu C-E.  2020.  Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.. JAMA Netw Open. 3(10):e2017666.
Friedberg JS, Aytan N, Cherry JD, Xia W, Standring OJ, Alvarez VE, Nicks R, Svirsky S, Meng G, Jun G et al..  2020.  Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype.. Sci Rep. 10(1):2924.
Wang L, Qiao Y, Zhang H, Zhang Y, Hua J, Jin S, Liu G.  2020.  Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank.. J Alzheimers Dis. 73(2):609-618.
Olive C, Ibañez L, Farias FHGeraldo, Wang F, Budde JP, Norton JB, Gentsch J, Morris JC, Li Z, Dube U et al..  2020.  Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.. J Alzheimers Dis. 77(4):1469-1482.
Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J et al..  2020.  Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.. Nat Commun. 11(1):667.
Ibañez L, Bahena JA, Yang C, Dube U, Farias FHG, Budde JP, Bergmann K, Brenner-Webster C, Morris JC, Perrin RJ et al..  2020.  Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease.. Acta Neuropathol Commun. 8(1):196.
Hofer E, Roshchupkin GV, Adams HHH, Knol MJ, Lin H, Li S, Zare H, Ahmad S, Armstrong NJ, Satizabal CL et al..  2020.  Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults.. Nat Commun. 11(1):4796.
Mukherjee S, Mez J, Trittschuh EH, Saykin AJ, Gibbons LE, Fardo DW, Wessels M, Bauman J, Moore M, Choi S-E et al..  2020.  Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.. Mol Psychiatry. 25(11):2942-2951.
Dumitrescu L, Mahoney ER, Mukherjee S, Lee ML, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J et al..  2020.  Genetic variants and functional pathways associated with resilience to Alzheimer's disease.. Brain. 143(8):2561-2575.
Sherva R, Gross A, Mukherjee S, Koesterer R, Amouyel P, Bellenguez C, Dufouil C, Bennett DA, Chibnik L, Cruchaga C et al..  2020.  Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.. Alzheimers Dement. 16(8):1134-1145.
Devanand DP, Lee S, Luchsinger JA, Andrews H, Goldberg T, Huey ED, Schupf N, Manly J, Stern Y, Kreisl WC et al..  2020.  Intact global cognitive and olfactory ability predicts lack of transition to dementia.. Alzheimers Dement. 16(2):326-334.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer